Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levofloxacin Pharmacokinetics in the Severely Obese
NCT00176306Phase 4Completed
- Start
- Jan 2005
- Primary completion
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of levofloxacin in bacterial infection. Primary endpoints: Plasma Concentration of Levofloxacin at 24 hours and Pharmacokinetic Parameters at 24 hours. Started Jan 2005; status: completed.
02
Drugs
levofloxacin
03
Conditions
bacterial infection
Beyond the preview
Go deeper on NCT00176306.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00176306.